Welcome to the Settlement Website for the Eagle Pharmaceuticals Securities Litigation

If you purchased the publicly traded common stock of Eagle Pharmaceuticals, Inc. between August 9, 2022 and October 1, 2024, both dates inclusive (the "Settlement Class Period"), you may be entitled to receive payment from this class action settlement.

Please read the Notice or review the Frequently Asked Questions page of this website for more information on your rights and options.


Your Legal Rights and Options in This Settlement
Rights and Options

Submit a Claim Form by October 16, 2026

This is the only way to be eligible to receive a payment. Proof of Claim and Release forms can be completed online, or a blank Claim Form is available for download on the Important Documents page.

Object to the settlement by July 29, 2026

Write to the Court about why you do not like the Settlement, the Plan of Allocation for distributing the proceeds of the Settlement, and/or Co-Lead Counsel’s Fee and Expense Application. If you object, you will still be in the Settlement Class.

Exclude yourself by July 29, 2026

Get no payment. This is the only option that, assuming your lawsuit is timely brought, might allow you to ever bring or be part of any other lawsuit against Defendants and/or the other Released Defendant Parties concerning the Released Plaintiffs’ Claims.

Participate in a Hearing on August 19, 2026 and File a Notice of Intention to Appear by July 29, 2026

Ask to speak in Court at the Settlement Hearing about the Settlement.

Do Nothing

Get no payment. Give up rights. Still be bound by the terms of the Settlement.


These rights and options—and the deadlines to exercise them—are explained further in the Notice and on the Frequently Asked Questions (FAQs) page of this website.

The Court must decide whether to approve the Settlement and the requested attorneys’ Fee Award and Costs. No Settlement Benefits will be provided unless the Court approves the Settlement.